Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Robb

Showing results (551-560 of 731) with videos related to

Pageof 74
Sort By:
Plos Pathogens|July 28, 2018
Evolution of HIV-1 within untreated individuals and at the population scale in UgandaJayna Raghwani, Andrew D Redd, Andrew F Longosz, et al.
Plos One|March 30, 2021
Clinical laboratory reference values in adults in Kisumu County, Western Kenya; hematology, chemistry and CD4Valentine Sing'oei, Jew Ochola, John Owuoth, et al.
Plos One|November 19, 2010
Phase I safety and immunogenicity evaluation of MVA-CMDR, a multigenic, recombinant modified vaccinia Ankara-HIV-1 vaccine candidateJeffrey R Currier, Viseth Ngauy, Mark S de Souza, et al.
The Lancet. Microbe|January 30, 2025
Vaccine efficacy of NVX-CoV2373 against SARS-CoV-2 infection in adolescents in the USA: an ancillary study to a phase 3, observer-blinded, randomised, placebo-controlled trialMeagan E Deming, Elizabeth R Brown, Monica A McArthur, et al.
Plos Pathogens|February 6, 2016
Production of Mucosally Transmissible SHIV Challenge Stocks from HIV-1 Circulating Recombinant Form 01_AE env SequencesLawrence J Tartaglia, Hui-Wen Chang, Benjamin C Lee, et al.
Cell Metabolism|December 30, 2015
Assessing the Mitochondrial Membrane Potential in Cells and In Vivo using Targeted Click Chemistry and Mass SpectrometryAngela Logan, Victoria R Pell, Karl J Shaffer, et al.
Vaccine|October 9, 2007
Induction of HIV-specific functional immune responses by a multiclade HIV-1 DNA vaccine candidate in healthy UgandansMichael A Eller, Leigh Anne Eller, Marc S Opollo, et al.
Nature Medicine|July 11, 2000
Human skin Langerhans cells are targets of dengue virus infectionS J Wu, G Grouard-Vogel, W Sun, et al.
Biomolecular Detection and Quantification|March 30, 2019
Next-generation sequencing of HIV-1 single genome ampliconsGustavo H Kijak, Eric Sanders-Buell, Phuc Pham, et al.
Science Translational Medicine|August 30, 2019
A vaccine-induced gene expression signature correlates with protection against SIV and HIV in multiple trialsPhilip K Ehrenberg, Shida Shangguan, Biju Issac, et al.
Pageof 74

Showing results (551-560 of 731) with videos related to

Sort By:
Pageof 74
Plos Pathogens|July 28, 2018
Evolution of HIV-1 within untreated individuals and at the population scale in UgandaJayna Raghwani, Andrew D Redd, Andrew F Longosz, et al.
Plos One|March 30, 2021
Clinical laboratory reference values in adults in Kisumu County, Western Kenya; hematology, chemistry and CD4Valentine Sing'oei, Jew Ochola, John Owuoth, et al.
Plos One|November 19, 2010
Phase I safety and immunogenicity evaluation of MVA-CMDR, a multigenic, recombinant modified vaccinia Ankara-HIV-1 vaccine candidateJeffrey R Currier, Viseth Ngauy, Mark S de Souza, et al.
The Lancet. Microbe|January 30, 2025
Vaccine efficacy of NVX-CoV2373 against SARS-CoV-2 infection in adolescents in the USA: an ancillary study to a phase 3, observer-blinded, randomised, placebo-controlled trialMeagan E Deming, Elizabeth R Brown, Monica A McArthur, et al.
Plos Pathogens|February 6, 2016
Production of Mucosally Transmissible SHIV Challenge Stocks from HIV-1 Circulating Recombinant Form 01_AE env SequencesLawrence J Tartaglia, Hui-Wen Chang, Benjamin C Lee, et al.
Cell Metabolism|December 30, 2015
Assessing the Mitochondrial Membrane Potential in Cells and In Vivo using Targeted Click Chemistry and Mass SpectrometryAngela Logan, Victoria R Pell, Karl J Shaffer, et al.
Vaccine|October 9, 2007
Induction of HIV-specific functional immune responses by a multiclade HIV-1 DNA vaccine candidate in healthy UgandansMichael A Eller, Leigh Anne Eller, Marc S Opollo, et al.
Nature Medicine|July 11, 2000
Human skin Langerhans cells are targets of dengue virus infectionS J Wu, G Grouard-Vogel, W Sun, et al.
Biomolecular Detection and Quantification|March 30, 2019
Next-generation sequencing of HIV-1 single genome ampliconsGustavo H Kijak, Eric Sanders-Buell, Phuc Pham, et al.
Science Translational Medicine|August 30, 2019
A vaccine-induced gene expression signature correlates with protection against SIV and HIV in multiple trialsPhilip K Ehrenberg, Shida Shangguan, Biju Issac, et al.
Pageof 74